Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A study at Oxford University Hospitals (OUH) NHS Foundation Trust has revealed the different levels of risk faced by healthcare workers dealing with the COVID-19 pandemic.

Outside the John Radcliffe Hospital

In a major collaboration with the University of Oxford, almost 10,000 staff were tested both for presence of the virus responsible for COVID-19 and antibodies to the virus. In combination these tests give an accurate view of who has had coronavirus infection to date in the OUH workforce.

There have been many studies looking at COVID-19 in healthcare workers, but this study, released today in a medRxiv preprint, is the first to comprehensively investigate all staff groups across an institution, and combines data from both symptomatic and asymptomatic staff testing programmes. The programme was able to 

  • identify and isolate staff members who had the infection before they developed symptoms, preventing them passing infection on to other staff and patients
  • identify in which areas of the hospital staff were at greatest risk 
  • identify which staff groups were at greatest risk 
  • record which staff have antibodies to the virus that causes COVID-19, enabling these staff to be monitored to understand if these antibodies provide immunity against repeat infections.

Based on the findings of the testing, OUH was able to implement an infection prevention and control plan to limit transmission of the virus.

The full story is available on the Oxford University Hospitals (OUH) NHS Foundation Trust website

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.